Clinical Trial Update: Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics (blood levels), potential drug interactions, and the effects of repeated dosing of GSK1034702 in individuals w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders

Drugs mentioned

• GSK1034702

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cognitive Disorders | Phase 1 | Status: COMPLETED